Scarica l'app Stockscreener
5.98
0.50%
-0.03
Dopo l'orario di chiusura:
6.07
0.09
+1.51%
Precedente Chiudi:
$6.01
Aprire:
$6
Volume 24 ore:
1.13M
Relative Volume:
2.72
Capitalizzazione di mercato:
$141.07M
Reddito:
-
Utile/perdita netta:
$-52.07M
Rapporto P/E:
-28.79
EPS:
-0.2077
Flusso di cassa netto:
$-44.93M
1 W Prestazione:
-21.73%
1M Prestazione:
-22.14%
6M Prestazione:
-19.84%
1 anno Prestazione:
-32.69%
Intervallo 1D:
$5.93
$6.49
Intervallo di 1 settimana:
$5.81
$7.71
Portata 52W:
$4.81
$13.88
Cybin Inc Stock (CYBN) Company Profile
Nome
Cybin Inc
Settore
Industria
Telefono
908 764 8385
Indirizzo
100 King Street West, Suite 5600, Toronto
Confronta CYBN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CYBN
Cybin Inc
|
5.98 | 147.20M | 0 | -52.07M | -44.93M | -0.2077 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Cybin Inc Stock (CYBN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-13 | Iniziato | Guggenheim | Buy |
| 2021-11-19 | Downgrade | Maxim Group | Buy → Hold |
Cybin Inc Borsa (CYBN) Ultime notizie
Cybin Inc. to Present at Cantor Global Healthcare Conference, Highlighting Neuropsychiatry Pipeline - citybuzz -
Is Cybin Inc. a potential multi baggerWeekly Earnings Recap & AI Enhanced Market Trend Forecasts - khodrobank.com
Can swing trading help recover from Cybin Inc. losses2025 Growth vs Value & AI Powered Market Entry Strategies - Newser
Cybin to Participate in Cantor Global Healthcare Conference 2025 with Fireside Chat by CMO Amir Inamdar - AInvest
Cybin to Participate in the Cantor Global Healthcare Conference 2025 - FinancialContent
Regression analysis insights on Cybin Inc. performanceJuly 2025 Summary & High Conviction Buy Zone Alerts - Newser
Cybin Inc. (CYBN) Launches Global Phase 3 Trial for Breakthrough Depression Therapy - MSN
Will Cybin Inc. stock go up soonQuarterly Performance Summary & Daily Volume Surge Signals - Newser
Should you wait for a breakout in Cybin IncWeekly Gains Report & Community Consensus Trade Alerts - Newser
Should you wait for a breakout in Cybin Inc.July 2025 EndofMonth & Reliable Price Breakout Alerts - Newser
Will Cybin Inc. price bounce be sustainablePortfolio Performance Report & Low Drawdown Investment Strategies - Newser
What to expect from Cybin Inc. in the next 30 daysJuly 2025 Market Mood & Weekly High Potential Stock Alerts - Newser
Why Cybin Inc. is moving todayWeekly Trade Review & High Win Rate Trade Alerts - Newser
Visualizing Cybin Inc. stock with heatmapsLong Setup & Weekly Return Optimization Plans - Newser
Cybin Announces Shareholder Meeting Results and Strategic Developments - MSN
Volatility clustering patterns for Cybin Inc.Trade Risk Assessment & Precise Trade Entry Recommendations - Newser
Is Cybin Inc. stock showing strong momentumProduct Launch & Safe Swing Trade Setups - khodrobank.com
Cybin Inc. shares rise 7.53% after-hours following CEO Doug Drysdale's resignation and Eric So's appointment as interim CEO. - AInvest
Cybin Inc. Announces Leadership Transition as Eric So Assumes Interim CEO Role - citybuzz -
Cybin announces senior leadership changes - MarketScreener
Can Cybin Inc. lead its sector in growthWatch List & Capital Efficiency Focused Strategies - khodrobank.com
Cybin Announces Senior Leadership Changes - Business Wire
Real time social sentiment graph for Cybin Inc.Jobs Report & Short-Term Swing Trade Alerts - Newser
Cybin Inc. recovery potential after sell offEarnings Overview Summary & AI Forecast Swing Trade Picks - Newser
Has Cybin Inc. Stock Ever Crashed Historical Volatility ReviewJuly 2025 Outlook & AI Powered Trade Plan Recommendations - Newser
Cybin Inc. (CYBN): A High-Potential Play in Psychedelic Psychiatry with Phase 3 Momentum and $500M in Backing - AInvest
Cybin Inc. Launches Global Phase 3 Trial for Breakthrough Depression Treatment, Secures $500M Financing - AInvest
Analyzing drawdowns of Cybin Inc. with statistical toolsPortfolio Gains Report & Real-Time Sentiment Analysis - Newser
Is Cybin Inc. stock overvalued or fairly pricedBond Market & Fast Gain Stock Tips - khodrobank.com
Can Cybin Inc. be the next market leaderJuly 2025 Analyst Calls & Consistent Profit Trade Alerts - khodrobank.com
Will earnings trigger a reversal in Cybin Inc.July 2025 Market Mood & Real-Time Stock Movement Alerts - Newser
Momentum divergence signals in Cybin Inc. chartPortfolio Growth Summary & Low Risk Growth Stock Ideas - Newser
What does recent volatility data suggest for Cybin Inc.2025 Earnings Surprises & High Accuracy Investment Entry Signals - Newser
What recent financial news should I pay attention to? - AInvest
Pattern recognition hints at Cybin Inc. upsideJuly 2025 PostEarnings & Free AI Powered Buy and Sell Recommendations - Newser
Building trade automation scripts for Cybin Inc.2025 Short Interest & Verified Short-Term Trading Plans - Newser
Risk vs reward if holding onto Cybin Inc.Trade Risk Assessment & Free Daily Entry Point Trade Alerts - Newser
Is Cybin Inc. stock good for income investorsQuarterly Portfolio Review & Smart Money Movement Alerts - kpenews.com
How to build a dashboard for Cybin Inc. stockJuly 2025 Catalysts & Community Consensus Stock Picks - Newser
Cybin Inc Azioni (CYBN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Capitalizzazione:
|
Volume (24 ore):